BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
111.93
-0.83 (-0.74%)
At close: Jan 17, 2025, 4:00 PM
113.00
+1.07 (0.96%)
After-hours: Jan 17, 2025, 7:05 PM EST
BioNTech SE Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for BioNTech SE stock have an average target of 145.28, with a low estimate of 122 and a high estimate of 172. The average target predicts an increase of 29.80% from the current stock price of 111.93.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BioNTech SE stock from 16 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 5 | 6 | 8 | 8 | 9 |
| Buy | 1 | 2 | 2 | 3 | 4 | 4 |
| Hold | 6 | 7 | 6 | 3 | 3 | 3 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 14 | 14 | 14 | 15 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Initiates $172 | Strong Buy | Initiates | $172 | +53.67% | Jan 10, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $170 | Buy | Initiates | $170 | +51.88% | Dec 11, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $171 → $171 | Strong Buy | Maintains | $171 → $171 | +53.17% | Nov 27, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $124 → $122 | Hold | Maintains | $124 → $122 | +9.00% | Nov 26, 2024 |
| Evercore ISI Group | Evercore ISI Group | Hold → Buy Upgrades $110 → $125 | Hold → Buy | Upgrades | $110 → $125 | +11.68% | Nov 19, 2024 |
Financial Forecast
Revenue This Year
2.69B
from 3.82B
Decreased by -29.51%
Revenue Next Year
2.62B
from 2.69B
Decreased by -2.86%
EPS This Year
-3.13
from 3.83
EPS Next Year
-3.45
from -3.13
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 3.0B | 3.5B | 3.6B | |||
| Avg | 2.7B | 2.6B | 2.6B | |||
| Low | 2.4B | 1.8B | 1.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -21.4% | 31.6% | 38.7% | |||
| Avg | -29.5% | -2.9% | -0.3% | |||
| Low | -38.4% | -34.0% | -34.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.35 | -0.06 | 1.45 | |||
| Avg | -3.13 | -3.45 | -3.23 | |||
| Low | -4.89 | -7.37 | -7.40 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.